Here are Daljeet Singh Kohli's top trading ideas

Watch the interview of Daljeet Singh Kohli of India Nivesh Securites with Ekta Batra & Anuj Singhal on CNBC-TV18, in which he shared his readings and outlook specific stocks and sectors.Below is the verbatim transcript of Daljeet Singh Kohli's interview with CNBC-TV18Majesco"Majesco has lot more potential though the stock has moved up in the last 2-3 days. Its a play on US insurance sector and it will scale up to a large company. They have taken over two companies and added 30 more clients to them and they are now present in the entire value chain, right from initiation of policy to the claim settlement.""We believe that over the next three years when the company starts getting the scale of USD 300 million, its margins will improve from 12 percent to 18 percent and this 9 times EV to sale will narrow down and that will give a huge upside. So we can get a target of Rs 549. Majsco looks to be a good and safe bet for the next one year," he said.Aurobindo Pharma"Aurobindo Pharma's numbers were good, infact they have shown 25 percent kind of growth in US. It has one of the largest filings in the Abbreviated New Drug Application (ANDA), they did around 360 odd filings and 162 filings are pending till Q2 end. Regulatory risks with regards to other big players is much lesser for the company. There is potential in Aurobindo Pharma, we have increased the price target to Rs 980 with a one year view. There is good potential there."